Navigation Links
Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries

The world's first 3D biosensor surface for label-free biomolecular interaction analysis now offers surface chemistries for: carboxyl, streptavidin, benzaldehyde, NTA-Ni for His-tagged proteins, Protein A and Protein G for coupling antibodies.

San Diego, CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., the pioneering life sciences tool company which introduced the world's first 3D biosensor surface for label-free biomolecular interaction analysis, announced the availability of three new surface chemistries: NTA-Ni, Protein A and Protein G.

Featuring biosensors with 3D nanoporous silicon chips, Silicon Kinetics SKi Pro™ is the world's only label-free biomolecular interaction analysis platform which allows high throughput ranking in multiwell plates and data-rich kinetic measurements in flow cells, all using the same reader instrument and the same surface chemistry. Available surface chemistries now include: carboxyl, streptavidin, benzaldehyde (a unique covalent surface which requires no activation step) and the newly introduced NTA-Ni for His-tagged proteins, Protein A and Protein G for coupling antibodies. Silicon Kinetics Surface Stabilization Following Indirect Capture of a Binding Partner Application Note

Using silicon biochips coated with its carboxyl chemistry, Silicon Kinetics recently announced measuring very slow off-rates in tight-binding molecules, down to 10 (-6) sec (-1), performance not feasible on biochips read by traditional SPR instruments. Silicon Kinetics Kinetic Characterization of Ultra-high Affinity Antibodies Application Note

About Silicon Kinetics

Silicon Kinetics, Inc. is a privately-held life sciences tools company headquartered in San Diego, California. The Company specializes in instruments for optical interferometry in nano-porous silicon biochips. The SKi Pro™ instrument platform and the 3D SKi Sensor™ biochips are used to detect protein-protein, protein-drug, or protein-DNA interactions in real-time and quantify binding kinetics, dissociation rates, or biomolecular affinity rankings, required for the study of disease pathways and the development and manufacturing of therapeutics. More information can be found at Silicon Kinetics.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. New silicon-germanium nanowires could lead to smaller, more powerful electronic devices
2. Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution
3. Understanding mechanical properties of silicon nanowires paves way for nanodevices
4. Saint-Gobain Introduces Next Generation Silicone Tubing
5. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
6. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
7. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
8. Stretching silicon: A new method to measure how strain affects semiconductors
9. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
10. Stretchable silicon camera next step to artificial retina
11. Silicon photonic crystals key to optical cloaking, researchers say
Post Your Comments:
Related Image:
Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):